Stocktoria
Advanced Biomed Inc. ADVB
Nasdaq · stock · Services-Medical Laboratories · website · IPO 2025-03-06
Advanced Biomed Inc. financials (annual)
Bars are annual figures from 2024 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | $127,637 | — | — |
| R&D expense | — | $909,771 | $880,193 |
| Operating income | -$6.2M | -$1.1M | — |
| Income tax | -$1,205 | — | — |
| Net income | $6.7M | -$3.3M | -$2.8M |
| EPS (diluted) | $5.33 | $-3.18 | $-0.14 |
| Operating cash flow | -$1.9M | -$5.8M | -$2.1M |
| Free cash flow | — | -$5.9M | -$2.2M |
| Total assets | $13.8M | $22.9M | $4.5M |
| Total liabilities | $1.5M | $19.4M | $2.8M |
| Shareholders' equity | $12.3M | $3.5M | $1.7M |
Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.